MAPT and Alzheimer disease: Alzheimer's disease (AD) is a progressive neurodegenerative disease of the brain characterized by extracellular β-amyloid plaques, intraneuronal neurofibrillary tau tangles, inflammation and glial responses, vascular dysfunction, cholinergic neurodegeneration, and synapse loss that directly correlates with cognitive decline and memory loss.